Effects of Encapsulated Propolis on Blood Glycemic Control, Lipid Metabolism, and Insulin Resistance in Type 2 Diabetes Mellitus Rats

Table 2

Effects of encapsulated propolis on FINS and IAI in T2DM Rats (𝑥  ± S.D.).

Group	Dosage (administration)	𝑛	Fasting serum insulin (μIU/mL)	Insulin action index
Normal control	1 mL/100 g; distilled water (p.o.)	12	39.75±10.85 **	−5.44±0.30 **
Model control	1 mL/100 g; distilled water (p.o.)	12	55.85±7.87	−6.17±0.22
Low-dose EP	50 mg/kg; encapsulated propolis (p.o.)	12	43.65±8.32	−5.79±0.27 **
Middle dose EP	100 mg/kg; encapsulated propolis (p.o.)	12	40.80±10.99 **	−5.60±0.55 **
High-dose EP	200 mg/kg; encapsulated propolis (p.o.)	12	44.21±5.50	−5.76±0.14 **
Positive control	10 mg/kg; Pioglitazone HCL (p.o.)	12	40.55±14.88 **	−5.64±0.20 **

The data were measured at the end of study. *𝑃<.05 and **𝑃<.01 compared with model control group.